James Hembach-Stunden

James Hembach-Stunden is a Principal Scientist at Odyssey Therapeutics since May 2022, previously holding the position of Senior Scientist. Prior to this, James served as a Senior Scientist and Scientist at IFM Therapeutics from March 2018 to May 2022. James Hembach-Stunden earned a Doctor of Philosophy (PhD) in Molecular Biology from The University of Bonn between 2011 and 2018, and a Bachelor of Biotechnology with Honours from Monash University from 2007 to 2011.